Shots:
- The companies expanded the collaboration to support the needs of patients with kidney disease via digital health solutions. The agreement integrates Ayogo’s LifePlan digital platform with Baxter’s expertise in renal care to develop mobile apps and digital solutions that bring personalized and timely support to patients with kidney failure
- Baxter made an equity investment in Ayogo in exchange for a minority interest in the company. The new initiative will provide patients the ability to proactively manage their home dialysis therapy records in collaboration with their healthcare team
- Earlier, the two companies collaborated to develop a patient engagement app, CKD&Me that provides customized disease and therapy education for the learning needs of patients with CKD. The companies have launched the app in the US and are preparing to expand it globally
Click here to read full press release/ article | Ref: Baxter | Image: StraitTimes
